Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model

Infection and Immunity

Volumn 76, Issue 6, 2008, Pages 2379-2391

  Chen, Gwo Hsiao ^a,b   McNamara, David A ^a,b   Hernandez, Yadira ^b   Huffnagle, Gary B ^b   Toews, Galen B ^a,b   Olszewski, Michal A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; EXPERIMENTAL MODEL; FEMALE; FUNGEMIA; HETEROSIS; HYBRID; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; INFECTION RESISTANCE; INFECTION SENSITIVITY; INHERITANCE; LOEFFLER PNEUMONIA; LUNG INFECTION; LYMPHATIC DRAINAGE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; ANIMAL; CYTOLOGY; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFLAMMATION; LUNG; LUNG MYCOSIS; MALE; METABOLISM; MICROBIOLOGY; MOUSE STRAIN; TIME;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; FEMALE; FUNGEMIA; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION; LUNG; LUNG DISEASES, FUNGAL; MALE; MICE; MICE, INBRED STRAINS; PULMONARY EOSINOPHILIA; TIME FACTORS;

EID: 46249085507     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01143-07     Document Type: Article

References (41)

1. Aguirre, K., J. Crowe, A. Haas, and J. Smith. 2004. Resistance to Cryptococcus neoformans infection in the absence of CD4 T cells. Med. Mycol. 42:15-25.
2. Arora, S., Y. Hernandez, J. R. Erb-Downward, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2005. Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J. Immunol. 174:6346-6356.
3. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans, 1st ed., vol. 1. ASM Press, Washington, DC.
4. Casadevall, A., and L. A. Pirofski. 2003. The damage-response framework of microbial pathogenesis. Nat. Rev. Microbiol. 1:17-24.
5. Chen, G. H., R. A. McDonald, J. C. Wells, G. B. Huffnagle, N. W. Lukacs, and G. B. Toews. 2005. The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect. Immun. 73:1788-1796.
6. Chen, G. H., M. A. Olszewski, R. A. McDonald, J. C. Wells, R. Paine III, G. B. Huffnagle, and G. B. Toews. 2007. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am. J. Pathol. 170:1028-1040.
7. Chuck, S. L., and M. A. Sande. 1989. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. New Engl. J. Med. 321:794-799.
8. Dresser, D. W. 1982. Quantitative inheritance of heterophile rheumatoid factor responsiveness in mice. J. Immunogenet. 9:31-42.
9. Heath, S. C., G. Bulfield, R. Thompson, and P. D. Keightley. 1995. Rates of change of genetic parameters of body weight in selected mouse lines. Genet. Res. 66:19-25.
10. Herbert, J. G., J. F. Kidwell, and H. B. Chase. 1979. The inheritance of growth and form in the mouse. IV. Changes in the variance components of weight, tail length and tail width during growth. Growth 43:36-46.
11. Hernandez, Y., S. Arora, J. R. Erb-Downward, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2005. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J. Immunol. 174:1027-1036.
12. Herring, A. C., N. R. Falkowski, G. H. Chen, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2005. Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells. Infect. Immun. 73:39-49.
13. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell Mol. Biol. 13:487-495.
14. Hoang, L. M. N., J. A. Maguire, P. Doyle, M. Fyfe, and D. L. Roscoe. 2004. Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology. J. Med. Microbiol. 53:935-940.
15. Hofman, V., N. Venissac, C. Mouroux, C. Butori, J. Mouroux, and P. Hofman. 2004. Disseminated pulmonary infection due to Cryptococcus neoformans in a non immunocompromised patient. Ann. Pathol. 24:187-191. (In French.)
16. Huffnagle, G. B., M. B. Boyd, N. E. Street, and M. F. Lipscomb. 1998. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J. Immunol. 160:2393-2400.
17. Huffnagle, G. B., G. H. Chen, J. L. Curtis, R. A. McDonald, R. M. Strieter, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol. 155:3507-3516.
18. Huffnagle, G. B., J. L. Yates, and M. F. Lipscomb. 1991. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J. Exp. Med. 173:793-800.
19. Huffnagle, G. B., J. L. Yates, and M. F. Lipscomb. 1991. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun. 59:1423-1433.
20. Kawakami, K., Y. Koguchi, M. H. Qureshi, S. Yara, Y. Kinjo, A. Miyazato, A. Nishizawa, H. Nariuchi, and A. Saito. 2000. Circulating soluble CD4 directly prevents host resistance and delayed-type hypersensitivity response to Cryptococcus neoformans in mice. Microbiol. Immunol. 44:1033-1041.
21. Kawakami, K., X. Qifeng, M. Tohyama, M. H. Qureshi, and A. Saito. 1996. Contribution of tumour necrosis factor-α (TNF-α) in host defence mechanism against Cryptococcus neoformans. Clin. Exp. Immunol. 106:468-474.
22. Kawakami, K., M. Tohyama, Q. Xie, and A. Saito. 1996. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol. 104:208-214.
23. Kechichian, T. B., J. Shea, and M. Del Poeta. 2007. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect. Immun. 75:4792-4798.
24. Kovacs, J. A., A. A. Kovacs, M. Polis, W. C. Wright, V. J. Gill, C. U. Tuazon, E. P. Gelmann, H. C. Lane, R. Longfield, G. Overturf, et al. 1985. Cryptococcosis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 103:533-538.
25. Lindell, D. M., M. N. Ballinger, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2006. Immunologic homeostasis during infection: coexistence of strong pulmonary cell-mediated immunity to secondary Cryptococcus neoformans infection while the primary infection still persists at low levels in the lungs. J. Immunol. 177:4652-4661.
26. Lindell, D. M., T. A. Moore, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2006. Distinct compartmentalization of CD4+ T-cell effector function versus proliferative capacity during pulmonary cryptococcosis. Am. J. Pathol. 168:847-855.
27. Lindell, D. M., T. A. Moore, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2005. Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection. J. Immunol. 174:7920-7928.
28. Lortholary, O., L. Improvisi, C. Fitting, J. M. Cavaillon, and F. Dromer. 2002. Influence of gender and age on course of infection and cytokine responses in mice with disseminated Cryptococcus neoformans infection. Clin. Microbiol. Infect. 8:31-37.
29. Mantovani, A., M. Muzio, C. Garlanda, S. Sozzani, and P. Allavena. 2001. Macrophage control of inflammation: negative pathways of regulation of inflammatory cytokines. Novartis Foundation symposium. 234:120-135.
30. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677-686.
31. Marroni, M., E. Pericolini, E. Cenci, F. Bistoni, and A. Vecchiarelli. 2007. Functional defect of natural immune system in an apparent immunocompetent patient with pulmonary cryptococcosis. J. Infect. 54:e5-e8.
32. Milam, J. E., A. C. Herring-Palmer, R. Pandrangi, R. A. McDonald, G. B. Huffnagle, and G. B. Toews. 2007. Modulation of the pulmonary type 2 T-cell response to Cryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha-expressing adenoviral vector. Infect. Immun. 75:4951-4958.
33. Olszewski, M. A., G. B. Huffnagle, R. A. McDonald, D. M. Lindell, B. B. Moore, D. N. Cook, and G. B. Toews. 2000. The role of macrophage inflammatory protein-1α/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J. Immunol. 165:6429-6436.
34. Olszewski, M. A., G. B. Huffnagle, T. R. Traynor, R. A. McDonald, D. N. Cook, and G. B. Toews. 2001. Regulatory effects of macrophage inflammatory protein 1α/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect. Immun. 69:6256-6263.
35. Shao, X., A. Mednick, M. Alvarez, N. van Rooijen, A. Casadevall, and D. L. Goldman. 2005. An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. J. Immunol. 175:3244-3251.
36. Spitzer, E. D., S. G. Spitzer, L. F. Freundlich, and A. Casadevall. 1993. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341:595-596.
37. Syme, R. M., C. J. Wood, H. Wong, and C. H. Mody. 1997. Both CD4+ and CD8+ human lymphocytes are activated and proliferate in response to Cryptococcus neoformans. Immunology 92:194-200.
38. Traynor, T. R., W. A. Kuziel, G. B. Toews, and G. B. Huffnagle. 2000. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164:2021-2027.
39. Vecchiarelli, A., M. Dottorini, D. Pietrella, C. Monari, C. Retini, T. Todisco, and F. Bistoni. 1994. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol. 11:130-137.
40. Zahra, L. V., C. M. Azzopardi, and G. Scott. 2004. Cryptococcal meningitis in two apparently immunocompetent Maltese patients. Mycoses 47:168-173.
41. Zaragoza, O., M. Alvarez, A. Telzak, J. Rivera, and A. Casadevall. 2007. The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response. Infect. Immun. 75:2729-2739.